arrow
A

Alexander L. Greninger

university of washington school of medicine
H指数:74
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Containment of a Candidozyma auris Outbreak in an Acute Care Hospital using a Comprehensive Screening and Surveillance Program

使用全面的筛查和监测计划控制急性护理医院中一种新型酵母菌Candidozyma auris的暴发

2026-08-190
PRE
Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

儿童中与SARS-CoV-2感染风险相关的免疫相关性:一项前瞻性、社区为基础的队列研究

2026-07-180
OAAI
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models

高耐受性和口服有效性的开发候选药物GHP-88310/EIDD-3608在麻疹和呼吸道副黏病毒模型中的研究

2026-05-220
OA
Structural and mechanistic basis for antibody neutralization of the measles fusion protein

麻疹融合蛋白抗体中和的结构与机制基础

2026-04-060
OA
Differentiating mpox infection and vaccination using a validated multiplex orthopoxvirus IgG serology assay

利用验证的多重正痘病毒IgG血清学检测区分猴痘病毒感染和疫苗接种

2025-12-010
PRE
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2-LTR Circles Over 12 Weeks

使用度鲁特韦和/或马拉维若进行抗逆转录病毒疗法强化,并未影响12周内HIV-1细胞相关DNA、RNA及2-LTR环。

2025-10-010
OAAI
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

SARS-CoV-2变异株抗体反应的免疫相关性分析:ENSEMBLE疫苗有效性试验

2025-09-290
OAAI
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study

呼吸道合胞病毒疾病风险的关联因素:一项前瞻性队列研究

2025-09-260
OAAI
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

肌肉内或静脉内给予抗病毒单克隆抗体疗法快速清除可培养的SARS-CoV-2

2025-09-010
OAAI
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settings

评估Cepheid Xpert Xpress CoV-2/Flu/RSV plus在CLIA认证和CLIA豁免环境下对鼻及鼻咽标本的检测效果

2025-08-070
PREAI